Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Liver cancer
Closed
Phase 3
This trial is looking at comparing lenvatinib on its own with lenvatinib and pembrolizumab for advanced liver cancer.
Advanced liver cancer is liver cancer that has spread into the near by tissues or to another part of the body.
Recruitment start: 4 March 2019
Recruitment end: 28 April 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Palmer
Merck Sharp & Dohme Ltd
Last reviewed: 13 Jul 2020
CRUK internal database number: 16688
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
